Skip to content
Austin Top 50
Author:
Tasrif Pharmaceutical, LLC
Tasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155)
July 29, 2026